Her work paved the way for blockbuster obesity drugs. Now, she’s ...
Sep 8, 2023 · When Svetlana Mojsov heard the spring 2021 announcement, she was startled. The Canada Gairdner International Award, a prestigious biomedical research prize, would be bestowed on three scientists for work underpinning the diabetes and obesity drugs that have exploded in popularity in recent years.
The Rockefeller University » Svetlana Mojsov wins the 2024 …
Sep 19, 2024 · Svetlana Mojsov has been named a 2024 recipient of the Lasker~DeBakey Clinical Medical Research Award, generally regarded as America’s top prize in biomedical research.
Svetlana Mojsov named 2024 recipient of the Pearl Meister ... - News
Feb 28, 2024 · Svetlana Mojsov, whose research into hormonal triggers for insulin production led to groundbreaking treatments for diabetes and obesity, will receive the 2024 Pearl Meister Greengard Prize, The Rockefeller University announced today.
Weight-loss-drug pioneer: this biochemist finally gained …
Dec 13, 2023 · Svetlana Mojsov led early studies of GLP-1, the hormone behind Wegovy, Ozempic and other blockbusters.
Lasker awardee Svetlana Mojsov describes a yearlong journey
Sep 19, 2024 · Chemist Svetlana Mojsov made key discoveries involving the glucagon-like peptide-1 receptor in the 1980s. Lori Chertoff/Rockefeller University. The Lasker Awards, announced today, are among the most prestigious prizes in biomedicine and basic biology.
Obesity-drug pioneers win prestigious Lasker Award for medical …
Sep 19, 2024 · Joel Habener, Svetlana Mojsov and Lotte Bjerre Knudsen each contributed to the creation of the popular anti-obesity drugs, which mimic a hormone called glucagon-like peptide 1 (GLP-1), involved...
Lasker Award honors work that led to obesity drugs like Wegovy
Sep 19, 2024 · Svetlana Mojsov wins ‘America’s Nobel’ with Joel Habener and Lotte Knudsen for research on popular obesity drugs. Svetlana Mojsov is one of three recipients of the prestigious Lasker-DeBakey...
The Rockefeller University » Svetlana Mojsov named one of ... - News
Apr 17, 2024 · A research associate professor, Mojsov was named to the list for her groundbreaking discoveries about a blood sugar–regulating gut hormone called GLP-1, which paved the way for the blockbuster diabetes and obesity drugs Ozempic, Victoza, and Wegovy.
Svetlana Mojsov named 2024 recipient of the Pearl Meister …
NEW YORK, Feb. 28, 2024 /PRNewswire/ -- Svetlana Mojsov, whose research into hormonal triggers for insulin production led to groundbreaking treatments for diabetes and obesity, will receive the...
Svetlana Mojsov, chemist: ‘I don’t know if they erased me from …
Jun 8, 2024 · Mojsov discovered the active sequence of an intestinal hormone — GLP-1 — which stimulates the pancreas to release more insulin when blood sugar is high. This discovery made it possible...